| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 803,098 | 640,620 | 521,434 | 512,867 | | Cost of Revenue | 341,617 | 288,059 | 257,630 | 252,732 | | | Gross Profit | 461,481 | 352,561 | 263,804 | 260,135 | | | Operating Expenses | | Research Development | 222,239 | 192,664 | 200,249 | 207,579 | | Selling General and Administrative | 56,028 | 60,946 | 134,142 | 63,872 | | Non Recurring | (13,292) | 4,956 | 8,336 | 9,689 | | Others | 26,450 | 26,446 | 30,356 | 48,274 | | | | Total Operating Expenses | 291,425 | 285,012 | 373,083 | 329,414 | | | | Operating Income or Loss | 170,056 | 67,549 | (109,279) | (69,279) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,303) | 1,793 | (72) | 1,678 | | Earnings Before Interest And Taxes | 168,753 | 69,342 | (109,351) | (67,601) | | Interest Expense | 70 | 1,514 | 88 | 2,118 | | Income Before Tax | 168,683 | 67,828 | (109,439) | (69,719) | | Income Tax Expense | (32,916) | 9,335 | 2,018 | (4,709) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 201,599 | 58,493 | (111,457) | (65,010) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 201,599 | 58,493 | (111,457) | (65,010) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $201,599 | $58,493 | ($111,457) | ($65,010) |
|
0.51% Nasdaq 
Income Statement
